XML 95 R69.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Compensation (Details) (USD $)
 12 Months Ended 1 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended
Jan. 28, 2012
plan
Jan. 29, 2011
Jan. 30, 2010
Jan. 28, 2012
Employee Stock Purchase Plan
month
Jan. 29, 2011
Employee Stock Purchase Plan
month
Jan. 30, 2010
Employee Stock Purchase Plan
month
Jan. 23, 2002
Employee Stock Purchase Plan
Oct. 31, 2008
Stock options
Jan. 28, 2012
Stock options
year
Jan. 29, 2011
Stock options
year
Jan. 30, 2010
Stock options
year
May 31, 2008
Nonvested stock awards/units
Jan. 28, 2012
Nonvested stock awards/units
year
Jan. 29, 2011
Nonvested stock awards/units
Jan. 30, 2010
Nonvested stock awards/units
Jun. 30, 2011
Nonvested stock awards/units
Maurice Marciano
year
Jan. 28, 2012
Nonvested stock awards/units
Maurice Marciano
Jan. 28, 2012
2004 Equity Incentive Plan
Stock options
month
year
Jan. 29, 2011
2004 Equity Incentive Plan
Stock options
Jan. 28, 2012
2006 Non-Employee Directors Stock Grant and Stock Option Plan
Stock options
Jan. 29, 2011
2006 Non-Employee Directors Stock Grant and Stock Option Plan
Stock options
May 09, 2006
2006 Non-Employee Directors Stock Grant and Stock Option Plan
Stock options
Jul. 30, 1996
2006 Non-Employee Directors Stock Grant and Stock Option Plan
Stock options
Disclosure of share-based compensation information under stock plans                                              
Number of share-based compensation plans 4                                            
Authorized number of shares             4,000,000                     20,000,000   2,000,000   1,000,000 1,000,000
Shares available for grant under the plan                                   13,429,837 13,723,669 930,338 951,373    
Term of award (in years)                                   P10Y          
Portion of vested and fully exercisable shares granted on each anniversary from the date of grant (as a percent)                                   25.00%          
Initial vesting period of the first of three most recent annual grants (in months)                                   9          
Initial vesting period of the second of three most recent annual grants (in months)                                   10          
Initial vesting period of the last of three most recent annual grants (in months)                                   9          
Number of annual vesting periods following the initial vesting period (in years)                                   3          
The purchase price expressed as a percentage of the Company's common stock at the beginning or end of the quarterly stock purchase period       85.00%                                      
Term of consulting agreement (in years)                               2              
Original grant date fair value of the modified equity awards                                 $ 4,700,000            
Modified grant date fair value                                 5,000,000            
Accelerated compensation expense to be recorded over the remainder of fiscal 2012                                 2,500,000            
Nonvested stock awards or units granted (in shares)                       167,000 347,535                    
Vesting period (in years)               4 years       5 years                      
Share-based compensation expense 28,100,000 29,312,000 27,339,000 393,000 358,000 365,000     7,123,000 7,755,000 8,051,000   20,584,000 21,199,000 18,923,000                
Number of Shares                                              
Options outstanding at the beginning of the period (in shares)                 2,204,319                            
Granted (in shares)               563,400 384,600                            
Exercised (in shares)                 (337,809)                            
Forfeited (in shares)                 (233,825)                            
Options outstanding at the end of the period (in shares)                 2,017,285 2,204,319                          
Exercisable at the end of the period (in shares)                 1,209,010                            
Options exercisable and expected to vest at the end of the period (in shares)                 1,979,293                            
Weighted Average Exercise Price                                              
Options outstanding at the beginning of the period (in dollars per share)                 $ 27.50                            
Granted (in dollars per share)                 $ 36.71                            
Exercised (in dollars per share)                 $ 21.30                            
Forfeited (in dollars per share)                 $ 33.42                            
Options outstanding at the end of the period (in dollars per share)                 $ 29.61 $ 27.50                          
Exercisable at the end of the period (in dollars per share)                 $ 27.91                            
Options exercisable and expected to vest at the end of the period (in dollars per share)                 $ 29.53                            
Weighted Average Remaining Contractual Term (Years)                                              
Options outstanding at the end of the period (in years)                 6.91                            
Exercisable at the end of the period (in years)                 6.01                            
Options exercisable and expected to vest at the end of the period (in years)                 6.87                            
Aggregate Intrinsic Value                                              
Options outstanding at the end of the period (in dollars)                 10,577,000                            
Exercisable at the end of the period (in dollars)                 8,325,000                            
Options exercisable and expected to vest at the end of the period (in dollars)                 10,551,000                            
Valuation Assumptions                                              
Risk-free interest rate (as a percent)       0.10% 0.10% 0.20%     1.10% 1.40% 1.30%                        
Expected stock price volatility (as a percent)       49.00% 43.40% 62.30%     48.50% 47.80% 61.30%                        
Expected dividend yield (as a percent)       2.20% 1.60% 2.40%     2.20% 1.60% 1.80%                        
Expected life of stock options (in years/months)       3 3 3     3.7 3.7 3.7                        
Share-Based Compensation, Additional Disclosures                                              
Weighted average fair values of stock options granted during the period (in dollars per share)                 $ 11.58 $ 14.36 $ 8.97                        
Total intrinsic value of options exercised (in dollars)                 5,900,000 24,900,000 19,700,000                        
Cash received from option exercises                 7,200,000 19,900,000 7,400,000                        
Excess tax benefits from share-based compensation 1,992,000 8,700,000 6,133,000           1,100,000       900,000                    
Compensation expense included in SG&A expense                         20,600,000                    
Excess tax shortfall included in cash flows from operating activities                 400,000       1,500,000                    
Income tax benefit on recognized compensation cost                 2,700,000       7,500,000                    
Unrecognized compensation cost, net of estimated forfeitures, related to nonvested stock options/awards/units                 $ 7,100,000       $ 16,100,000                    
Weighted-average period for recognition of unrecognized compensation cost (in years)                 1.6       1.6